Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function

被引:321
作者
Udagawa, N
Takahashi, N
Yasuda, H
Mizuno, A
Itoh, K
Ueno, Y
Shinki, T
Gillespie, MT
Martin, TJ
Higashio, K
Suda, T
机构
[1] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan
[2] Snow Brand Milk Prod Co Ltd, Tochigi 3290512, Japan
[3] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1210/en.141.9.3478
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoprotegerin (OPG), a soluble decoy receptor for receptor activator of nuclear factor-kappa B ligand (RANKL)/osteoclast differentiation factor, inhibits both differentiation and function of osteoclasts. We previously reported that OPG-deficient mice exhibited severe osteoporosis caused by enhanced osteoclastic bone resorption. In the present study, potential roles of OPG in osteoclast differentiation were examined using a mouse coculture system of calvarial osteoblasts and hone marrow cells prepared fi om OPG-deficient mice. in the absence of bone-resorbing factors, no osteoclasts were formed in cocultures of wild-type (+/+) or heterozygous (+/-) mouse-derived osteoblasts with bone marrow cells prepared from homozygous (-/-) mice. In contrast, homozygous (-/-) mouse-derived osteoblasts strongly supported osteoclast formation in the cocultures with homozygous (-/-) bone marrow cells, even in the absence of bone-resorbing factors. Addition of OPG to the cocultures with osteoblasts and bone marrow cells derived from homozygous (-/-) mice completely inhibited spontaneously occurring osteoclast formation. Adding 1 alpha,25-dihydroxyvitamin D-3 [1 alpha,25(OH)(2)D-3] to these cocultures significantly enhanced osteoclast differentiation. In addition, bone-resorbing activity in organ cultures of fetal long bones derived from homozygous (-/-) mice was markedly increased, irrespective of the presence and absence of bone-resorbing factors, in comparison with that from wild-type (+/+) mice. Osteoblasts prepared from homozygous (-/-), heterozygous (+/-), and wild-type (+/+) mice constitutively expressed similar levels of RANKL messenger RNA, which were equally increased by the treatment with 1 alpha,25(OH)(2)D-3. When homozygous (-/-) mouse-derived osteoblasts and hemopoietic cells were cocultured, hut direct contact between them was prevented, no osteoclasts were formed, even in the presence of 1 alpha,25(OH)(2)D-3 and macrophage colony-stimulating factor. These findings suggest that OPG produced by osteoblasts/stromal cells is a physiologically important regulator in osteoclast differentiation and function and that RANKL expressed by osteoblasts functions as a membrane-associated form.
引用
收藏
页码:3478 / 3484
页数:7
相关论文
共 35 条
[1]   Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy [J].
Akatsu, T ;
Murakami, T ;
Ono, K ;
Nishikawa, M ;
Tsuda, E ;
Mochizuki, SI ;
Fujise, N ;
Higashio, K ;
Motoyoshi, K ;
Yamamoto, M ;
Nagata, N .
BONE, 1998, 23 (06) :495-498
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[4]   RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[5]   The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [J].
Hofbauer, LC ;
Khosla, S ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :2-12
[6]   Activated T lymphocytes support osteoclast formation in vitro [J].
Horwood, NJ ;
Kartsogiannis, V ;
Quinn, JMW ;
Romas, E ;
Martin, TJ ;
Gillespie, MT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :144-150
[7]   Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. [J].
Horwood, NJ ;
Elliott, J ;
Martin, TJ ;
Gillespie, MT .
ENDOCRINOLOGY, 1998, 139 (11) :4743-4746
[8]   Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand [J].
Hsu, HL ;
Lacey, DL ;
Dunstan, CR ;
Solovyev, I ;
Colombero, A ;
Timms, E ;
Tan, HL ;
Elliott, G ;
Kelley, MJ ;
Sarosi, I ;
Wang, L ;
Xia, XZ ;
Elliott, R ;
Chiu, L ;
Black, T ;
Scully, S ;
Capparelli, C ;
Morony, S ;
Shimamoto, G ;
Bass, MB ;
Boyle, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3540-3545
[9]  
Jimi E, 1999, J IMMUNOL, V163, P434
[10]   Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand [J].
Kong, YY ;
Feïge, U ;
Sarosi, I ;
Bolon, B ;
Tafuri, A ;
Morony, S ;
Capparelli, C ;
Li, J ;
Elliott, R ;
McCabe, S ;
Wong, T ;
Campagnuolo, G ;
Moran, E ;
Bogoch, ER ;
Van, G ;
Nguyen, LT ;
Ohashi, PS ;
Lacey, DL ;
Fish, E ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 402 (6759) :304-309